SupportMAX OCS - 30 servings

Regular price £39.00
Sale
£39.00
Regular price £0.00
/
Tax included. Shipping calculated at checkout.

£39.00 GBP
£37.05 GBP

Auto-renews, skip or cancel anytime.

To add to cart, go to the product page and select a purchase option

Description

SupportMAX, the undisputed champion of on-cycle support, born from a time when such products were scarce, and the quality left much to be desired. In an era where discussing performance-enhancing drugs (PEDs) was shrouded in taboo, SupportMAX emerged as a game-changer, redefining the landscape of athletic supplementation.

What sets SupportMAX apart is its elegant simplicity combined with unparalleled efficacy. While other products may boast high doses of ingredients, we focused on sourcing only the highest-quality components that have stood the test of time. The result is a formula that proves time and again that more doesn't always mean better.

As the market leader in on-cycle support, SupportMAX has garnered immense popularity among athletes, bodybuilders, and fitness enthusiasts worldwide. Our commitment to delivering a safe, effective, and reliable product has earned us the trust and loyalty of our customers. With SupportMAX, you can embark on your journey with confidence, knowing that you have a steadfast ally by your side.

During the years Rick has developed other products that compliments SupportMAX perfectly. People often use SystolMAX, GlutathioneMAX, LipidMAX and ThromboMAX alongside this OG OCS.

Serving

Serving size: 4 capsules
Servings per container: 30

Nutritional Information

Ingredient Per 4 capsules %RI*

Vitamin D

5000IU 1250%
Magnesium 40mg 10%

Selenium

100mg 142%

N-Acetyl-L-Cysteine

1000mg **

Citrus Bergamot

500mg **

Betaine HCL

500mg **

TUDCA

250mg **

COQ10

100mg **

Hawthorn Berry

100mg **

Dandelion Root Extract

100mg **

 RI = Reference Intake
** No Reference Intake 

 

Directions

Take 4 capsules daily spread throughout the day.

Ingredients + Allergens

Ingredients: N-Acetyl-L-Cysteine, Citrus Bergamot, Betaine HCL, Tauroursodeoxycholic acid, Co Enzyme Q10, Hawthorn Berry, Dandelion Root Extract, Vitamin D, Magnesium Citrate, Selenium, Magnesium Stearate, Di Calcium Phosphate, Gelatin Capsule

Allergen Advice:  For allergens, see ingredients in bold. Produced in a facility that handles Milk, Soy, Egg and Gluten.

Not suitable for Vegetarians. Not suitable for Vegans.

Warnings:

Do not exceed the recommended daily dose. As with all supplementation, please consult your physician prior to use (especially if you have a medical health condition). Not recommended for anyone under the age of 18. Do not take this product if pregnant or breastfeeding. If you are taking any medications consult your doctor before use. This product is not intended to cure or prevent any disease or illness. This product should not be used as a substitute for a varied and balanced diet and healthy lifestyle. Keep out of reach of children. Store in a cool, dry place. Best before: See base

Studies

Selenium is necessary for normal cardiovascular function.” European Food standards agency health claim - ID 280 https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2009.1220

N-Acetyl Cysteine – 1,000mg

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270338/

Co-Q10 100mg - European Food standards agency health claim Maintenance of normal blood pressure European Food standards agency health claim (ID 1509, 1721, 1911)

https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2010.1793

TUDCA 250mg

https://www.sciencedirect.com/science/article/pii/S0011393X05806599

Betaine HCL 500mg

https://www.ncbi.nlm.nih.gov/pubmed/23980906

Citrus Bergamot 500mg

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702027/

Dandelion Root Extract 100mg

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155102/

Hawthorn Berry 100mg

Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease (Pharmacogn Review 2010)

"Vitamin D contributes to normal cell division" - European Food standards agency health claim ID 153 - https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2009.1227